DIOSynVax Presents Its Technology at the Invitation-Only
CAMBRIDGE, United Kingdom and SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) — DIOSynVax, a clinical-stage biotechnology company at the forefront of developing safe, innovative, broadly protective vaccines presented its unique broad-based vaccine technology at the London Stock Exchange sponsored by Venture Capital Unit, Department for Business & Trade at an invitation-only, investor-only Health Tech event. The … Read more